Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 27

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 27
---
 dividends, but rather merely represent the right to acquire shares of Common Stock at a fixed price. Specifically, commencing
on the date of issuance, holders of the Offered Common Warrants may exercise their right to acquire Common Stock and pay an exercise
price of $1.96 per share, subject to certain adjustments, prior to five years from the date on which such Offered Common Warrants were
issued, after which date any unexercised Offered Common Warrants will expire and have no further value. Holders of Pre-Funded Warrants
have identical rights, except that the Pre-Funded Warrants have an exercise price of $0.001 and do not expire until exercised in full.
Moreover, following this offering, the market value of the Offered Common Warrants and Pre-Funded Warrants, if any, is uncertain and
there can be no assurance that the market value of the Offered Common Warrants or the Pre-Funded Warrants will equal or exceed their
imputed offering price.

Holders of the Offered Common Warrants and Pre-Funded Warrants offered hereby will have no rights as common stockholders with respect to the shares our common stock underlying the Offered Common Warrants and Pre-Funded Warrants until such holders exercise their Offered Common Warrants and Pre-Funded Warrants and acquire our common stock, except as otherwise provided in the Offered Common Warrants and Pre-Funded Warrants.

Until holders of the Offered
Common Warrants and Pre-Funded Warrants acquire shares of our Common Stock upon exercise thereof, such holders will have no rights with
respect to the shares of our Common Stock underlying such warrants. Upon exercise of the Offered Common Warrants and Pre-Funded Warrants,
the holders will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after
the exercise date. This is a best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the
amount of capital we believe is required for our business plan.

The placement agent has
agreed to use its reasonable best efforts to solicit offers to purchase the securities in this offering. The placement agent has no obligation
to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities.
There is no required minimum number of securities that must be sold as a condition to completion of this offering. Because there is no
minimum offering amount required as